Abstract 4807
Background
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a comprehensive treatment of peritoneal malignancies and it is currently a viable option in the increasing number of specialized centers all around the world.
Methods
A review of 119 CRS/HIPEC patients operated between 2007-2017 in a tertiary referral center of Bogotá, Colombia was performed. Patient characteristics, surgical variables, and postoperative outcomes were prospectively collected and analyzed.
Results
Median age at diagnosis was 51-yo (r, 22-78) and 73% (n = 87) were female. Primary origin of the peritoneal carcinomatosis was the appendix in 64%, advanced ovarian and primary peritoneal carcinomas (PC) in 17%, colorectal cancer (CRC) in 10.1%, peritoneal mesothelioma (PM) in 9%, and others in 1.6%. Prior surgical Peritoneal Cancer Index (PCI) was 19 (r, 2-39) and 25.2% were exposed to preoperative chemotherapy. Complete cytoreduction rate (CCR) was 81.5% (75% appendiceal tumors, 94% OC, 83% CRC, and 100% PM [p = 0.81]). Grade III, IV, and V complications were reported in 10%, 12%, and 4% of patients, respectively. Progression-free survival (PFS) was 38.4 months (95%CI 12.6-64.3) and 5-year PFS was 64%. PFS was positively influenced by appendiceal and mesothelioma histology (p = 0.035) as well as complete cytoreduction (p = 0.0001). At 42-month median follow-up 26 patients have died and the median overall survival (OS) was 108.5 months (95%CI 77.5-139.5). OS of patients with t relapse was 78.6 months (95% CI 36.1-121.1) and NR (p = 0.002), respectively, and only this variable adversely affected the multivariate analysis (RR 3.7, 95% CI 1.4-9.5; p = 0.007).
Conclusions
CRS/HIPEC is an effective treatment for patients with PC providing long-term survival and should be considered as standard of care. Our results, from a specialized center in a developing Latin-American country, are comparable to those from first-world centers, implying the importance of group experience in providing high-quality outcomes. Results showed that patients without relapse at the 5th year follow-up could be considered cured, but should always resume observation.
Clinical trial identification
Legal entity responsible for the study
Fundacion Santa Fe de Bogotá.
Funding
Fundacion Santa Fe de Bogotá.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract